Different target systems, overlapping only in the GHK-Cu component
They can aid in glycemic control, weight loss, and carry a low risk of hypoglycemia
Krekels, alongside collaborators Chiara Campana Kemal, PhD and Manash Chatterjee from Merck for their contributions to this important work advancing model informed drug development
Sattar N, Lee MMY, Kristensen SL et al (2021) Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Its the most efficient one
How Much is GLP-1 Without Insurance